NCT00630552 2024-10-17QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerNantCell, Inc.Phase 1/2 Completed138 enrolled 19 charts
NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT00630786 2014-02-06Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyAmgenPhase 1/2 Completed53 enrolled 13 charts